Switching from Escitalopram to Desvenlafaxine

Introduction to Cross-Tapering

When switching from escitalopram to desvenlafaxine, a cross-tapering approach with gradual reduction of escitalopram while introducing desvenlafaxine at 50 mg daily is recommended to minimize discontinuation symptoms and avoid serotonin syndrome, as suggested by the American Academy of Child and Adolescent Psychiatry 1

Escitalopram can cause discontinuation syndrome characterized by dizziness, fatigue, headaches, nausea, sensory disturbances, anxiety, and irritability, according to the American Academy of Child and Adolescent Psychiatry 1
Gradual tapering reduces the risk of discontinuation symptoms, as noted in Pediatrics 2
Both medications affect serotonin levels, creating a potential risk for serotonin syndrome during cross-tapering, as indicated by the American Academy of Child and Adolescent Psychiatry 1

For elderly patients, consider a more gradual cross-tapering schedule, as recommended by the American Academy of Child and Adolescent Psychiatry 1

Abrupt discontinuation of escitalopram significantly increases the risk of discontinuation syndrome, as warned by Pediatrics 2
Adjusting the cross-tapering schedule based on individual tolerance and response is crucial, as suggested by the American Academy of Child and Adolescent Psychiatry 1